Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-[(3S)-1-[7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl]-1-[3-(2,5-dichloro-4-{[3-(4-cyclopropyl-1,2,3,4-tetrahydroquinoxaline-1-carbonyl)pyridin-4-yl]oxy}phenyl)-N-methylpropanamido]-3,6,9,12,15,18-hexaoxahenicosan-21-amide
ID: ALA5275304
Max Phase: Preclinical
Molecular Formula: C67H80Cl2N12O12
Molecular Weight: 1316.35
Associated Items: